Further, they conducted in vitro assays and utilized patient-derived xenografts to show that an inhibitor specifically targeting the phosphorylation of Ser897 effectively inhibited metastasis in ICC cases with mutated EPHA2 [116]. Here, EPHA2 is linked to intrahepatic cholangiocarcinoma.